NCT05515328View on ClinicalTrials.gov

A Study in Healthy Men to Test How BI 685509 is Processed in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 8, 2022

Primary Completion Date

November 17, 2022

Study Completion Date

November 17, 2022

Conditions
Healthy
Interventions
DRUG

[¹⁴C] BI 685509 formulation 1

\[¹⁴C\] BI 685509 formulation 1

DRUG

[¹⁴C] BI 685509 formulation 2

\[¹⁴C\] BI 685509 formulation 2

DRUG

BI 685509 formulation 3

BI 685509 formulation 3

Trial Locations (1)

9728 NZ

ICON, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body | Biotech Hunter | Biotech Hunter